Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020
Chiara Pavanello, Laura Calabresi
Current Opinion in Lipidology (2020) Vol. 31, Iss. 4, pp. 232-237
Closed Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Familial LCAT Deficiency and Low HDL-C Levels: In silico Characterization of Two Rare LCAT Missense Mutations
Sebastian Ciro Acosta, Lorena Díaz-Ordóñez, Juan David Gutiérrez-Medina, et al.
The Application of Clinical Genetics (2024) Vol. Volume 17, pp. 23-32
Open Access
Die Hornhaut als Indikator für Systemerkrankungen
Berthold Seitz, Jens Martin Rohrbach
Springer Reference Medizin (2024), pp. 1-15
Closed Access
Novel pathogenic variant in the LCAT gene in a compound heterozygous patient with fish-eye disease and a mild phenotype
Masaaki Miyata, Masayuki Kuroda, Junko Miyoshi, et al.
Journal of clinical lipidology (2024) Vol. 19, Iss. 1, pp. 125-133
Open Access
A Rare Case of Autoimmune-Mediated Lecithin:Cholesterol Acyltransferase Insufficiency Manifesting as the Acute Onset of Extremely Hypo-High-Density Lipoprotein-Cholesterolemia and Spontaneous Improvement: A Case Report with a Review of the Literature
Atsuko Tamaki, Masayuki Kuroda, K. Yonaha, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency
Monica Gomaraschi, Marta Turri, Arianna Strazzella, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1498-1498
Open Access | Times Cited: 1
Serum opacity factor normalizes erythrocyte morphology in Scarb1−/− mice in an HDL-free cholesterol-dependent way
Ziyi Wang, Dedipya Yelamanchili, Jing Liu, et al.
Journal of Lipid Research (2023) Vol. 64, Iss. 11, pp. 100456-100456
Open Access | Times Cited: 1
High-density lipoproteins
Valentin Blanchard, Gordon A. Francis
Elsevier eBooks (2021), pp. 487-514
Closed Access | Times Cited: 2
Familial lecithin-cholesterol acyltransferase deficiency: If so rare, why so frequent in the state of Piauí, northeastern Brazil?
Rafael Melo Santos de Serpa Brandão, Fábio Barros Britto, José Tibúrcio do Monte Neto, et al.
Molecular Genetics and Metabolism Reports (2022) Vol. 30, pp. 100840-100840
Open Access | Times Cited: 1
Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency
Margareta Fištrek Prlić, Marijana Ćorić, Laura Calabresi, et al.
Atherosclerosis Plus (2022) Vol. 49, pp. 28-31
Open Access | Times Cited: 1
Lipid disorders in children: diagnosis and treatment
Khashayar Farzam
Future Cardiology (2022) Vol. 18, Iss. 12, pp. 915-920
Closed Access | Times Cited: 1
Genetic testing in dyslipidaemia: An approach based on clinical experience
Amanda J. Berberich, Robert A. Hegele
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 37, Iss. 3, pp. 101720-101720
Closed Access | Times Cited: 1
A novel pathogenic variant in LCAT causing FLD. A case report
Nuria Goñi Ros, Ricardo González‐Tarancón, P Bailo, et al.
Acta Clinica Belgica (2021) Vol. 77, Iss. 6, pp. 970-975
Closed Access | Times Cited: 1
DNA testing in dyslipidemia: attitudes and complexities
Robert A. Hegele
Current Opinion in Lipidology (2023) Vol. 34, Iss. 2, pp. 33-34
Closed Access
Gene Therapy and Therapeutic Genome Editing in Liver for Lipid Disorders
Daniel J. Rader
Elsevier eBooks (2023), pp. 281-285.e1
Closed Access
Lipoprotein Z, an abnormal LDL-like lipoprotein, independently predicts mortality in cirrhosis
Eline H. van den Berg, Jose L. Flores‐Guerrero, Robin P.F. Dullaart
European Journal of Internal Medicine (2022) Vol. 101, pp. 128-129
Open Access
Renal Manifestations of Metabolic Disorders in Children
Francesco Emma, Matthias R. Baumgartner, Diego Martinelli, et al.
Pediatric Nephrology (2022), pp. 779-798
Closed Access
A rare case of renal involvement in Lecithin-Cholesterol Acyltransferase (LCAT) deficiency: lessons for the clinical nephrologist
Ashutosh Rath, Zafirah Zahir, Manoj Jain, et al.
Journal of Nephrology (2022) Vol. 36, Iss. 2, pp. 319-321
Closed Access
Renal Involvement in Lysosomal Storage Disorders (Fabry’s Disease, Niemann–Pick Disease) and LCAT Deficiency
Pallav Gupta, Ramesh K. Gupta
(2022), pp. 263-277
Closed Access
Renal Manifestations of Metabolic Disorders in Children
Francesco Emma, Matthias R. Baumgartner, Diego Martinelli, et al.
Pediatric Nephrology (2021), pp. 1-20
Closed Access
Previous Page - Page 2

Scroll to top